(Q38364391)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

review article

1 reference

title

Pharmacogenomic information in drug labels: European Medicines Agency perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Adrián Llerena

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

F Ehmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

L Caneva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

K Prasad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Paulmichl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Maliepaard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Papaluca-Amati

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Ingelman-Sundberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

24 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

201-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/tpj.2014.86

1 March 2020

exact match

0 references

cites work

Ethical and social issues in pharmacogenomics testing

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Pathology practice and pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Pharmacogenomics and individualized drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Response variability to P2Y12 receptor inhibitors: expectations and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Genetics of platelet inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

Policies to aid the adoption of personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.86

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25707393

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutant KRAS codon 12 and 13 alleles in patients with metastatic colorectal cancer: assessment as prognostic and predictive biomarkers of response to panitumumab

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25707393

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25707393

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/TPJ.2014.86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25707393%20AND%20SRC:MED&resulttype=core&format=json